SOLV — Solventum Corporation stock price, charts and financials

QT66Solventum Corporation

Solventum Corporation (NYSE: SOLV) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
85.48
+2.50+3.01%
SOLVQT66Solventum Corporation·NYSE
85.48+3.01%
News
Up 3.0% — Here's Why Solventum (SOLV) is a Strong Momentum Stock (zacks.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500P/E10.09EPS (ttm)8.22Insider Own-Shs Outstand173.17MPerf Week-2.88%
Market Cap14.37BForward P/E11.42EPS next Y7.27Insider Trans0.00%Shs Float147.07MPerf Month9.24%
Enterprise Value19.25BPEG0.04EPS next Q-Inst Own-Short Float2.92%Perf Quarter15.81%
Income1.43BP/S1.73EPS this Y-13.86%Inst Trans-Short Ratio2.60Perf Half Y7.79%
Sales8.31BP/B3.00EPS next Y3.28%ROA10.07%Short Interest4.30MPerf YTD4.72%
Book/sh-P/C-EPS next 5Y10.99%ROE28.96%52W High92.71 -7.80%Perf Year14.34%
Cash/sh-P/FCF-EPS past 3/5Y4.46% 6.11%ROIC15.85%52W Low64.26 33.02%Perf 3Y-
Dividend Est.-EV/EBITDA7.41Sales past 3/5Y0.79% 2.72%Gross Margin54.69%Volatility3.81% 3.04%Perf 5Y-
Dividend TTM-EV/Sales2.32EPS Y/Y TTM196.01%Oper. Margin24.99%ATR (14)2.84Perf 10Y-
Dividend Ex-Date-Quick Ratio0.74Sales Y/Y TTM0.10%Profit Margin17.26%RSI (14)52.75Recom2.36
Dividend Gr. 3/5Y-Current Ratio1.02EPS Q/Q10.45%SMA201.03%Beta0.65Target Price91.22
Payout0.00%Debt/Eq1.10Sales Q/Q-3.04%SMA504.61%Rel Volume0.65Prev Close82.98
Employees20,000LT Debt/Eq1.00EarningsNov 05SMA2009.74%Avg Volume1.66MPrice85.48
IPO DateApr 01, 2024Option/ShortYes / YesEPS/Sales Surpr.9.42% 2.01%Net Debt/EBITDA1.88Volume1,076,504Change3.01%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedStifel Nicolaus$90$100
Aug-06-26ReiteratedUBSBuy$95$101
Aug-06-26ReiteratedMizuho SecuritiesOutperform$100$113
Aug-06-26ReiteratedKeyBancOverweight$93$102
Aug-06-26ReiteratedBTIGBuy$91$95
Jul-28-26UpgradeUBSNeutralBuy$78$95
Jul-13-26ReiteratedBTIGBuy$89$91
Jul-08-26ReiteratedBMO Capital$81
Jun-01-26ReiteratedJefferies$43
May-15-26InitiatedWedbushOutperform$94
Latest News
Today
Aug-09-26
Aug-09-2603:04AM
Aug-06-26
Aug-05-26
Aug-04-26
Aug-03-26
Jul-29-26
Jul-29-2603:06AM
Jul-28-26
Company

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
Total Revenue8,3108,3258,254
Cost of Goods Sold Incl. D&A3,7653,8743,661
Gross Profit4,5454,4514,593
Selling, General and Administrative Excl. Other3,2933,0802,782
Research and Development726739775
Other Operating Expense-1,551-1,5490
Operating Income2,0772,1811,036
Interest Expense266347367
Unusual Expense
Non-Operating Income (Expense)-115-121-64
Net Income Before Taxes1,6961,713605
Income Taxes261157127
Consolidated Net Income1,4341,556479
Net Income From Continuing Operations1,4351,556478
Net Income1,4341,556479
EPS (Recurring)8.228.942.77
EPS (Basic, Before Extraordinaries)8.228.942.77
EPS (Diluted)8.198.882.76
EBITDA2,5982,5491,527
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio10.448.9223.93
Price To Sales Ratio1.791.661.38
Gross Margin54.6953.4755.65
Operating Margin24.9926.2012.55
Net Margin17.2618.695.80
Shares Outstanding174174173
Market Capitalization14,87413,78811,428
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$92.46$83.99$75.52$67.05$58.58 Close Price0.00M161.59M323.18M484.77M646.36MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Landucci AmyChief Information OfficerMay 13 '26Option Exercise0.004,422041,905May 15
Kirberger Marcela A.Chief Legal Affairs OfficerMay 13 '26Option Exercise0.004,488015,492May 15
Gomez Tammy LChief Human Resources OfficerMay 13 '26Option Exercise0.003,960015,030May 15
McMillan Wayde D.Chief Financial OfficerMay 13 '26Option Exercise0.009,503053,041May 15
Harrington Paul SChief Supply Chain OfficerMay 13 '26Option Exercise0.003,960022,130May 15
Wilcox Mary TChief Accounting OfficerMay 13 '26Option Exercise0.002,37607,632May 15
Hanson Bryan CChief Executive OfficerMay 13 '26Option Exercise0.0034,3150158,225May 15
Wendell Amy McBrideDirectorApr 30 '26Option Exercise0.003,403010,422May 01
WEILAND JOHN HDirectorApr 30 '26Option Exercise0.003,40308,947May 01
Mily ElizabethDirectorApr 30 '26Option Exercise0.003,40309,009May 01
Wilson Darryl L.DirectorApr 30 '26Option Exercise0.003,40308,947May 01
MAY KAREN JDirectorApr 30 '26Option Exercise0.003,40308,947May 01
Harris Bernard A JrDirectorApr 30 '26Option Exercise0.003,40308,947May 01
EISENBERG GLENN ADirectorApr 30 '26Option Exercise0.003,40308,947May 01
Edwards Shirley AnnDirectorApr 30 '26Option Exercise0.003,40308,947May 01
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.